Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM — Stella

Home/Gestational Diabetes/Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

View on ClinicalTrials.gov

Recruiting

Back to Gestational Diabetes trials

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of Iowa, Iowa City, Iowa

Key details

Phase

Very early testing

Sponsor

Anna Stanhewicz, PhD

Enrollment target

~40 participants

Started

August 2023

Primary completion

June 2027

Age range

18 Years – 50 Years

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.